Original Query: ALL
Previous Study | Return to List | Next Study

Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01265576
Recruitment Status : Unknown
Verified December 2015 by Vicus Therapeutics.
Recruitment status was:  Active, not recruiting
First Posted : December 23, 2010
Last Update Posted : December 9, 2015
Information provided by (Responsible Party):
Vicus Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : February 2014
  Estimated Study Completion Date : April 2016